The Price of Pain: There may be a link between financial hardship and pain during #cancer treatment. According to a retrospective cohort study, patients who reported a #financial hardship had a 37% higher risk of moderate/severe pain over six months.
#OncSky #MedSky
The American Society of Hematology is renaming of several of its honorific awards to more visibly honor the broad community of individuals whose work has advanced #hematology. Learn more about these trailblazing figures and their enduring legacies within the field: https://ow.ly/aR9h50Z6PVv
New research on IV iron indicates that ferric carboxymaltose is associated with a higher fracture risk than ferric derisomaltose in patients with #IronDeficiency due to its accumulation within osteoblasts and osteocytes, further impairing bone formation: https://ow.ly/3Yoo50Z7CNY
#HemeSky #MedSky
#Romiplostim was effective in treating chemotherapy-induced #thrombocytopenia and preventing its recurrence in certain cancers, resulting in a lower incidence of #chemotherapy dose modifications in patients with #gastrointestinal #cancer specifically: https://ow.ly/55to50Z8b5y
#HemeSky #MedSky
Despite having disease characteristics similar to patients in high-income countries, patients in #Malawi with indolent #lymphomas treated with #chemotherapy alone experience poor survival outcomes, with one- and two-year PFS standing at 44% and 28%: https://ow.ly/EEO650Z4Q8Y
#HemeSky #OncSky
The June issue is out now! Highlights include articles on the delayed diagnosis of #bleeding disorders in #women, #aspirin use in #pregnant patients with #SCD, microbiome wellness in #hematology, and more. See the full issue lineup here: https://ow.ly/rqVk50Z6PGc
The Quiet Fallout: Closer proximity to #nuclear power plants seem to have a negative effect on #cancer #mortality rates. Data showed that 115,586 cancer deaths during a 19-year analysis could be attributed to nuclear power plant proximity.
#MedSky #HemeSky
#ASCO26 Compared with SOC combination therapy, #teclistamab monotherapy prolonged survival and improved length and depth of response among patients with R/R #MMsm who had received 1-3 prior lines of therapy, producing an 18-month PFS of 69.8% vs. 26.9%: https://ow.ly/aa6250ZblQy
#HemeSky #OncSky
Frontline #eltrombopag plus IST demonstrated cost-effectiveness in severe #AplasticAnemia, yielding more discounted QALYs (11.53 vs. 10.73) compared with IST alone at an increased cost of $593,000 vs. $561,000, resulting in an ICER of $40,000 per QALY: https://ow.ly/8kjY50Z9oo7
#HemeSky #MedSky
See what's come in the June issue! Highlights include a feature on diagnostic delays in women with hematologic conditions, a lighthearted debate on #basophils and #MastCells, and the latest news in multiple #myeloma, aplastic #anemia, #lymphoma, and more: https://ow.ly/YCSg50Z4qxk
#HemeSky #MedSky
